Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Pacira BioSciences Inc shares valued at $116,267 were sold by BIGAL MARCELO on Aug 07 ’25. At $23.67 per share, BIGAL MARCELO sold 4,912 shares. The insider’s holdings dropped to 11,393 shares worth approximately $0.28 million following the completion of this transaction.
Also, BIGAL MARCELO purchased 4,912 shares, netting a total of over 116,279 in proceeds.
Before that, RIKER LAUREN had sold 5,578 shares from its account. In a trade valued at $146,208, the Senior Vice President, Finance traded Pacira BioSciences Inc shares for $26.21 each. Upon closing the transaction, the insider’s holdings decreased to 5,578 shares, worth approximately $1.49 million.
As published in a research note from Truist on July 25, 2025, Pacira BioSciences Inc [PCRX] has been rated up from a Hold to a Buy and the price target has been revised to $30. Analysts at Truist upgraded the stock from ‘”a Sell”‘ to ‘”a Hold”‘ outlook in a report released in late January. As of August 13, 2024, Truist has decreased its “Buy” rating to a “Sell” for PCRX. Earlier on August 12, 2024, RBC Capital Mkts downgraded its rating. Their new recommendation was “a Sector perform” for PCRX stock which previously was a “an Outperform”.
Analyzing PCRX Stock Performance
On last trading session, Pacira BioSciences Inc [NASDAQ: PCRX] plunged -0.20% to $24.99. The stock’s lowest price that day was $24.7019, but it reached a high of $25.35 in the same session. During the last five days, there has been a surge of approximately 5.13%. Over the course of the year, Pacira BioSciences Inc shares have jumped approximately 103.34%. Shares of the company reached a 52-week high of $27.64 on 04/08/25 and a 52-week low of $18.17 on 01/06/25.
Support And Resistance Levels for Pacira BioSciences Inc (PCRX)
According to the 24-hour chart, there is a support level at 24.68, which, if violated, would cause prices to drop to 24.37. In the upper region, resistance lies at 25.33. The next price resistance is at 25.66. RSI (Relative Strength Index) is 62.47 on the 14-day chart, showing neutral technical sentiment.
Is Pacira BioSciences Inc subject to short interest?
Stocks of Pacira BioSciences Inc saw a sharp rise in short interest on 2025-07-31 jumping by 92147.0 shares to 5.69 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 5.6 million shares. A jump of 1.62% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 9.86 of the overall float, the days-to-cover ratio (short ratio) jumped to 9.86.
Which companies own the most shares of Pacira BioSciences Inc (PCRX)?
In terms of Pacira BioSciences Inc share price expectations, FactSet research, analysts set an average price target of 36 in the next 12 months, up nearly 43.77% from the previous closing price of $25.04. Analysts anticipate Pacira BioSciences Inc stock to reach 48 by 2025, with the lowest price target being 24. In spite of this, 6 analysts ranked Pacira BioSciences Inc stock as Buy at the end of 2025.
